2011-05-20

The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership

Malaria Journal,

by Lacaze C, Kauss T, Kiechel JR, Caminiti A, Fawaz F, Terrassin L, Cuart S, Grislain L, Navaratnam V, Ghezzoul B, Gaudin K, White NJ, Olliaro P, Millet P. Malaria Journal, May 2011, 10:142. doi:10.1186/1475-2875-10-142.

Click here to read the article

Latest scientific articles

Stay connected

Get our latest news, personal stories, research articles, and job opportunities.

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership

Latest scientific articles

Strengthening health systems and clinical development capacities through effective partnerships: a case study of DNDi’s collaboration with the Leishmaniasis Research and Treatment Center in Ethiopia (2003–2022)

Efficacy and safety of oxfendazole in adults with Trichuris spp. infection in Pemba Island, Tanzania: a double-blind, phase 2a, randomised controlled trial

Deconvoluting the mode of action of antileishmanial aminopyrazoles through chemical mutagenesis

Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics

Stay connected

Learn more

Get in touch

Support us

Work with us